Grants and Contributions:

Back to search

Title:

Pilot Study to Assess Efficacy and Safety of a Novel Bath/Wash Treatment Against Sea Lice

Agreement Number:

916911

Agreement Value:

$49,645.00

Agreement Date:

Dec 3, 2018 - Mar 31, 2021

Description:

Infections by the parasitic copepod sea lice continue to be a challenge to most Atlantic salmon farming regions of the world, including Atlantic Canada. These host-specific parasites are very pathogenic to salmonid species (e.g. Atlantic salmon) especially populations in cage culture where the stocking density is unnaturally high. Large numbers of sea lice can quickly cause severe skin and tissue damage resulting in fish stress and mortality. RPS Biologiques has developed a novel compound that will undergo pilot-testing prior to further pre-commercial development, to determine and compare the efficacy with other commercially available bath treatments.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Charlottetown, Prince Edward Island, CA C1A 3H4

Reference Number:

172-2018-2019-Q3-916911

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

808567390

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.

Amendment Date

Jan 19, 2021

Recipient's Legal Name:

RPS Biologiques Inc.

Federal Riding Name:

Charlottetown

Federal Riding Number:

11002

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

32541

Amendments:

See Amendments